BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3260781)

  • 1. Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate.
    Murakawa Y; Sakane T
    Arthritis Rheum; 1988 Jul; 31(7):826-33. PubMed ID: 3260781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ
    Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal requirement for interleukin-1-dependent interleukin 2 production by a human leukemia-derived HSB.2 subclone.
    Mukaida N; Kasahara T; Yagisawa H; Shioiri-Nakano K; Kawai T
    J Immunol; 1987 Nov; 139(10):3321-9. PubMed ID: 3500216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus.
    Linker-Israeli M; Quismorio FP; Horwitz DA
    J Rheumatol; 1988 Aug; 15(8):1216-22. PubMed ID: 2972835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired T-cell activation in patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ; Lightfoot RW; Goodwin JS
    J Clin Immunol; 1989 Nov; 9(6):469-76. PubMed ID: 2517125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.
    Baran J; Kowalczyk D; Ozóg M; Zembala M
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):303-13. PubMed ID: 11238213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-signal requirement for interferon-gamma production by human large granular lymphocytes.
    Young HA; Ortaldo JR
    J Immunol; 1987 Aug; 139(3):724-7. PubMed ID: 3110282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L; Lipsky PE
    J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation.
    Hashimoto S; Takahashi Y; Tomita Y; Hayama T; Sawada S; Horie T; McCombs CC; Michalski JP
    Scand J Immunol; 1991 Apr; 33(4):393-403. PubMed ID: 2017664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective expression of p70/75 interleukin 2 receptor in T cells from patients with systemic lupus erythematosus: a possible defect in the process of increased intracellular calcium leading to p70/75 expression.
    Saiki O; Tanaka T; Kishimoto S
    J Rheumatol; 1990 Oct; 17(10):1303-7. PubMed ID: 2254888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH; Ledbetter JA; Lindsten T; Thompson CB
    J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired interleukin-2 production in active ulcerative colitis is reversed by calcium ionophore plus phorbol myristate acetate and related to altered intracellular Ca2+ responses.
    Kuroiwa A; Kusugami K; Shinoda M; Haruta J; Morise K
    Intern Med; 1994 Dec; 33(12):739-44. PubMed ID: 7718953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth, interleukin-2 production, and responsiveness to IL-2 in T4-positive T Lymphocyte populations from malignant cutaneous T cell lymphoma (Sézary's syndrome): the effect of cyclosporin A.
    Solbach W; Lange CE; Röllinghoff M; Wagner H
    Blood; 1984 Nov; 64(5):1022-7. PubMed ID: 6237693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
    Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
    Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the sodium periodate (NaIO4) response in systemic lupus erythematosus (SLE): effect of interleukin-1 (IL-1), interleukin-2 (IL-2), phorbol myristate acetate (PMA), and indomethacin.
    Phillips R; Lomnitzer R; Rabson AR
    Clin Immunol Immunopathol; 1985 Jan; 34(1):77-83. PubMed ID: 2981169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Azacytidine induced inhibition of mitogenic response by agents that activate or augment activation of human peripheral blood T lymphocytes.
    Deguchi Y; Negoro S; Hara H; Kishimoto S
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1395-401. PubMed ID: 2451522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.